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Abstract
Background: The increasing involvement of pharmacists in public health will require changes in the behaviour of
both pharmacists and the general public. A great deal of research has shown that attitudes and beliefs are
important determinants of behaviour. This review aims to examine the beliefs and attitudes of pharmacists and
consumers towards pharmaceutical public health in order to inform how best to support and improve this service.
Methods: Five electronic databases were searched for articles published in English between 2001 and 2010. Titles
and abstracts were screened by one researcher according to the inclusion criteria. Papers were included if they
assessed pharmacy staff or consumer attitudes towards pharmaceutical public health. Full papers identified for
inclusion were assessed by a second researcher and data were extracted by one researcher.
Results: From the 5628 papers identified, 63 studies in 67 papers were included. Pharmacy staff: Most pharmacists
viewed public health services as important and part of their role but secondary to medicine related roles.
Pharmacists’ confidence in providing public health services was on the whole average to low. Time was consistently
identified as a barrier to providing public health services. Lack of an adequate counselling space, lack of demand and
expectation of a negative reaction from customers were also reported by some pharmacists as barriers. A need for
further training was identified in relation to a number of public health services. Consumers: Most pharmacy users had
never been offered public health services by their pharmacist and did not expect to be offered. Consumers viewed
pharmacists as appropriate providers of public health advice but had mixed views on the pharmacists’ ability to do
this. Satisfaction was found to be high in those that had experienced pharmaceutical public health
Conclusions: There has been little change in customer and pharmacist attitudes since reviews conducted nearly
10 years previously. In order to improve the public health services provided in community pharmacy, training must
aim to increase pharmacists’ confidence in providing these services. Confident, well trained pharmacists should be
able to offer public health service more proactively which is likely to have a positive impact on customer attitudes
and health.
Background
Promotion of healthy lifestyles is one of the five core
roles of a pharmacist, as defined by the Royal Pharma-
ceutical Society of Great Britain, (RPSGB) [1]. Although
pharmacists have always had some involvement in health
improvement, the focus on this aspect has greatly
increased over recent years [2]. This changing role was
formalised by the introduction of the new pharmacy con-
tract in 2005 in England and Wales and 2006 in Scotland
which outlined the public health service pharmacists
would be required to provide. These services include pro-
vision of advice on healthy living and self care and invol-
vement in health promotion campaigns in Scotland,
England and Wales with the additional requirement to
provide a smoking cessation and sexual health service in
Scotland [3,4].
Community pharmacy holds a number of benefits as a
setting for public health activities. With extended opening
hours and no appointment needed for advice, community
pharmacy can be more accessible than other settings. An
estimated 600,000 people visit community pharmacies in
Scotland every day and approximately 94% of the Scottish
population visit a community pharmacy at least once in a
year [5]. This gives community pharmacies access to a
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range of individuals in both good and poor health, and to
those that may not have contact with any other health
professionals. Reviews of evidence assessing public health
initiatives in community pharmacy have confirmed the
potential of pharmacy in this area and suggest that phar-
macists can indeed make a positive contribution to public
health [6,7].
Although there is clear potential for pharmacy to con-
tribute in a unique way to public health, changes in the
behaviour of both pharmacists and pharmacy customers
are likely to be required for the service to be successful.
Pharmacists must accept their role in public health and
make the necessary changes in behaviour to carry out
the service. Similarly, the general public must accept
pharmacists as providers of public health services and
be willing to seek advice on some health issues from
pharmacists rather than other sources.
The factors that affect and predict behaviour have been
the subject of a great deal of research. The theory of
planned behaviour (TPB) is a model that has been widely
used to predict and change behaviour across a range of
settings [8]. The model states that voluntary behaviours
are largely predicted by our intentions regarding the
behaviour. Intentions are in turn determined by our atti-
tude towards the behaviour (our judgement of whether
the behaviour is a good thing to do), subjective norms
(our judgement of what important others think of the
behaviour), and perceived behavioural control (our
expectation of how successful we will be in carrying out
the behaviour). A review by Sutton found that on average
the TPB predicted between 40 and 50% of the variance in
intention and between 19 and 38% of the variance in
behaviour [9]. While theories such as the TPB cannot
entirely predict behaviour, these findings demonstrate
the important role of beliefs in understanding behaviour.
Therefore, in order to understand and assist the beha-
viour changes associated with providing a public health
service in community pharmacy, it is important to
establish the beliefs of the general public and pharma-
cists regarding this role. Three systematic reviews have
previously been carried out in this area. One assessed
pharmacist views and another general public views
towards various public health services [10,11]. The third
reviewed papers on the provision of emergency hormo-
nal contraception (EHC) in pharmacy and included pub-
lic and pharmacist views [12]. The review of
pharmacists’ perceptions of public health covered litera-
ture published up to 2001 and found that although
pharmacists valued the health improvement role they
were more comfortable with medicine related health
improvement work [10]. The review also found that
pharmacists had concerns about being intrusive and
believed they needed more support to provide public
health services. Training was found to positively affect
pharmacists’ attitudes and behaviours in relation to
health promotion [10].
The review on consumer views covered literature up
to 2002 and found that pharmacists were perceived as
‘drug experts’ rather than experts on health and illness.
Although consumers were generally satisfied with health
advice given by pharmacists, they primarily used phar-
macies for dispensing prescriptions and buying over the
counter medication [11]. The final review summarised
literature on the provision of EHC in pharmacy up to
the end of 2004. The review reported that the service
was largely viewed positively by both pharmacists and
service users but that some concerns were raised by
consumers regarding privacy [12].
Since these reviews were conducted, the introduction
of the new pharmacy contract has brought about a great
deal of change in community pharmacies. In order to
continue to improve the public health service provided in
community pharmacies, up to date information is needed
regarding the beliefs and attitudes of pharmacists and
consumers towards pharmaceutical public health. Beliefs
about the public health role may or may not be similar to
those found in the previous review. Establishing current
views would allow potential barriers to the public health
service to be established and appropriately tackled. The
objective of this review is to summarise and evaluate
quantitative and qualitative evidence published since the
previous reviews were conducted on the beliefs and atti-
tudes of pharmacists and consumers towards pharmaceu-
tical public health.
Methods
The electronic databases MEDLINE, EMBASE, PsycINFO,
CINAHL and Dissertation Abstracts International were
searched for articles published in English from February
2001 to February 2010. The following combination of
search terms was used with each database: (pharm* or
pharmacy staff or community pharmacy or consumer or
public or customer) and (attitud* or belie* or perce* or
knowledge or view or opinion) and (public health or
health improvement or health promotion or self care or
self management or smoking cessation or sexual health or
prevent* or diet or healthy diet or healthy eating or exer-
cise or physical activity or weight or health education or
chlamydia testing or emergency contraception or alcohol
or needle exchange or methadone or injecting equipment
or drug misuse).
Titles and abstracts were screened against the inclu-
sion criteria outlined in table 1. Full text papers were
retrieved for studies considered relevant and for those
with titles and abstracts that contained insufficient
information to allow judgement of relevance. The full
text papers were assessed against the inclusion criteria
by one researcher and those identified as relevant were
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checked again by a second researcher. Data were
extracted from included studies using a data extraction
form based on the example provided by the Centre for
Reviews and Dissemination [13]. In order to assess
methodological quality, studies were assessed against the
checklist outlined by Crombie which is suitable for use
with descriptive surveys [14]. The methodological qual-
ity of qualitative studies was assessed against the Critical
Appraisal Skills Programme checklist for qualitative
studies [15].
Results
Literature Search
A total of 5628 abstracts were reviewed and 122 full text
papers were assessed against the inclusion criteria out-
lined in Table 1. A second researcher assessed the 71
papers shortlisted for inclusion and 63 studies published
in 67 papers were included for review. Figure 1 shows
the flow of studies identified by the searches.
Description of Included Studies
The characteristics of the studies included in the review
are presented in additional file 1. The majority of studies
assessed the views of pharmacists (n = 29), support staff
(n = 3) or both (n = 1). Three studies investigated both
pharmacist and general public views and the remaining
studies assessed the views of the general public or phar-
macy customers (n = 27). The most common topics
investigated were sexual health services (n = 17), smoking
cessation (n = 14), general health promotion/screening (n
= 12), and services for drug misusers (n = 10). The
majority of studies were carried out in Europe (n = 31)
and North America (n = 23). The most commonly
employed methodology was surveys (n = 50). Eight stu-
dies used structured or semi-structured interviews, two
used focus groups and two studies used both focus group
and survey methods. Table 2 outlines the country of pub-
lication of papers included in the review sorted by topic
area. It shows the proportion of UK and non-UK papers
published after the introduction of the new pharmacy
contract in the UK (2006 to 2010).
Quality of Included Studies
Quality varied across the studies included. The quality of
reporting was often poor with 16 studies not reporting any
information on the age of participants [16-35], 8 not
reporting age or gender [36-43] and 2 not reporting gen-
der [44,45]. Fifteen studies did not report response rates
[17,25,29,43,46-56] and two only reported the response
rates for part of the sample [57,58]. Only three studies fol-
lowed up a sample of non-responders [59-61]. Response
rates where reported were generally average to good with
the majority (71%) achieving response rates of 50% and
over. The way participants were recruited was not clearly
reported in one study [50] and the results were not ade-
quately explained in another [62]. In the latter case, the
names of themes arising from the analysis of interviews
were stated with little explanation of the direction of opi-
nion of pharmacists in relation to these themes. The
majority of studies included in the review employed con-
venience sampling (n = 29), 5 used purposive sampling
[41,56,62-64] and only 13 used random sampling methods
[16,18,32-38,47,50,58,65-68]. Of the 12 studies included
that used qualitative methodologies only one employed
respondent validation [62] or made a statement of how
the personal characteristics of the researchers may have
influenced analysis [69]. Methods and analysis were not
adequately described in one study [43], data was not tran-
scribed verbatim in another study [70] and multiple cod-
ing was not used in two further studies [41,51].
Pharmacy Staff
The attitudes and beliefs of pharmacists and pharmacy
staff investigated in the papers included in this review
related to four main topics: perceptions of role, compe-
tence/confidence, barriers and training.
Table 1 Criteria for inclusion of studies in the review
Population Community pharmacists, community pharmacy support staff, pharmacy customers and members of the general public.
Phenomenon of
Interest
The phenomenon of interest was the attitudes and beliefs of the general public and community pharmacists towards the
public health role of community pharmacists. The activities included in the scope of pharmacy public health services in
this review include individual and community efforts to promote health, prevent and detect health problems and
promote self care in individuals with long term health conditions.
Primary Outcome
Measures
The outcome measures of interest included but were not restricted to the following:
• Pharmacists’ and general public’s beliefs about the skills and knowledge of pharmacists in providing public health
• Pharmacists’ and general public’s beliefs about the suitability of pharmacists and community pharmacy for providing
public health services.
• Pharmacists’ and general public’s beliefs about the most appropriate provider of public health services.
• Pharmacists’ beliefs about their confidence in carrying out public health services.
• Pharmacists’ beliefs about training needed for carrying out public health services.
• General public’s views about their experiences of public health services in community pharmacy.
• General public’s use of community pharmacies and knowledge of public health services provided in pharmacies.
Types of Studies Quantitative cross sectional surveys and qualitative studies. Studies were included if they reported one or more of the
outcomes detailed above.
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The reference lists of 63 remaining full text 
papers were searched and a further 5 studies 
were identified for inclusion:
68 full text papers
Assessment of titles and abstracts led to 122
full text papers being obtained that met 
inclusion criteria or for which there was 
insufficient detail to assess inclusion.
Search of MEDLINE, EMBASE, PsycINFO, 
CINAHL and Dissertation Abstracts 
International:
5628 titles and abstracts
Full papers that did not relate to 
the attitudes of pharmacists and 
general public towards
pharmaceutical public health:
59 full text papers
Titles and abstract that did not 
relate to the attitudes of 
pharmacists and general public 
towards pharmaceutical public 
health:
5506 titles and abstracts
63 studies in 67 papers included in review.
Assessment of full text papers by 
second researcher (RO) resulted 
in exclusion of 1 paper as the 
population did not meet the 
inclusion criteria. 
Figure 1 Flow diagram of searches and inclusion assessment of studies.
Table 2 Details of country and date of publication of included papers by topic area
Topic Total No.
of studies
No. of UK studies published
2006-2010 (% total UK
studies)
No. of non UK published
2006-2010 (% total non UK
studies)
Country Published (No.)
Smoking
Cessation
13 n/a 7 (54%) USA (7), Canada (2), Finland (1), Turkey (1),
Australia (1), Thailand (1).
EHC 12 1 (33%) 4 (44%) USA (4), UK (3), Sweden (2), Canada (1), Various
Europe (1), Australia (1).
Health
Promotion and
Screening
12 2 (66%) 6 (66%) UK (3), Sweden (2), Nigeria (2), Australia (2),
Moldova (1), Malaysia (1), USA (1).
Drug Misuse 12 6 (66%) 2 (66%) UK (9), USA (1), Vietnam (1), Estonia (1).
Chlamydia 5 4 (100%) 0 UK (4), The Netherlands (1).
Osteoporosis
Screening
3 1 (100%) 0 USA (2), UK (1).
Type 2 Diabetes 2 n/a 2 (100%) United Arab Emirates (1), USA (1).
Weight
Management
2 1 (100%) 0 USA (1), UK (1).
Alcohol
consumption
1 n/a 1 (100%) New Zealand (1).
Asthma
Management
1 n/a 1 (100%) Finland (1).
Total 63 15 (71%) 23 (55%) United Kingdom (21), Non-UK Europe (10),
North America (20), Asia (5), Oceania (5),
Africa (2).
Eades et al. BMC Public Health 2011, 11:582
http://www.biomedcentral.com/1471-2458/11/582
Page 4 of 13
Perceptions of Role
The majority of participants in a survey in Scotland
agreed (63%) or strongly agreed (16%) that public health
is important to their practice and a little over half
agreed (48%) or strongly agreed (8%) that they were
public health practitioners [21]. A survey in Nigeria also
reported that the majority of participants (94%) thought
it was acceptable for pharmacists to be involved in
health promotion activities [71]. Pharmacists and sup-
port staff taking part in focus groups in Sweden on the
whole welcomed their role as a health promoter [56].
However, it was noted that not all participants felt this
way and preferred to develop activities in areas in which
they received their basic training. Consistent with this, a
study in Moldova found that participants rated public
health activities significantly lower in importance than
all other aspects of professional practice assessed (e.g.
dispensing activities) [65]. Furthermore, a survey in
Scotland offering participants a choice of hypothetical
jobs found that participants would rather provide a
minor illness service than health promotion advice and
would forgo £2798 of income to do this [72].
Perceptions regarding the pharmacists’ role in smoking
cessation counselling were generally favourable. Nearly all
pharmacists surveyed in Thailand, Finland and the USA
agreed that they should play a role in smoking cessation
[45,37,16]. The majority of participants (83%) in another
survey in the USA believed that pharmacists should be
more active in assisting with smoking cessation [55]. How-
ever, in a survey in Turkey only 57% of participants
thought that pharmacists should warn patients about the
harmful effects of smoking [50]. A study in Canada found
that pharmacists rated medicine related aspects (e.g. advis-
ing on the use of NRT) of their smoking cessation role as
more important than other aspects (e.g. assessing patients’
dependence on nicotine) [34]. Another paper based on the
same sample found that participants were significantly
more likely to carry out smoking cessation interventions
with customers if they scored above the median in ratings
of importance of various smoking cessation roles [32].
Perceptions about the pharmacist’s role in sexual
health services were generally positive. The majority of
pharmacists (98%) surveyed in a study in Scotland
agreed that they would be willing to offer free Chlamy-
dia postal testing kits [26]. In a survey in the USA 55%
of pharmacists were interested in providing emergency
hormonal contraception (EHC) [68]. Pharmacists inter-
viewed in a study in the UK [69] were found to hold lar-
gely positive views about providing EHC. However,
around one quarter of pharmacists in another study in
the USA were opposed to providing EHC largely due to
religious and moral beliefs [67]. Pharmacists in the latter
two studies also reported concerns that the service may
be overused and lead to increases in unprotected sex
and sexually transmitted diseases [67,69]. The benefits
of providing this service that were highlighted by phar-
macists in these two studies included increasing access
to EHC, confidentiality, reducing unwanted pregnancies
and improving status of the pharmacy profession
[67,69].
Attitudes towards providing services for drug misusers
have become more favourable over recent years. Surveys
in England and Scotland in 2007 reported that attitudes
were significantly more positive since assessed in a simi-
lar survey in 1995 [38,60]. Similarly, a study in the USA
reported an increase in the number of pharmacists who
agreed that sterile needles should be made available
through community pharmacy [39].
Despite a shift in attitudes, views towards providing ser-
vices for drug misusers are still mixed. Pharmacists taking
part in focus groups in Estonia and a survey in the USA
highlighted a number of concerns about the effect of
selling sterile needles on customers and business [58,41].
Support staff in a survey in Scotland also reported similar
concerns [30]. Only half of support staff (52.6%) in this
study thought that their pharmacy should provide services
to drug misusers [31]. The possibility of providing free
injecting equipment to drug misusers was met with strong
resistance in the study in Estonia. The majority of pharma-
cists in a survey in Scotland disagreed or neither agreed or
disagreed that HIV/hepatitis prevention is an important
role for pharmacists [73].
However pharmacists supplying sterile needles for pur-
chase in the USA and UK reported few problems provid-
ing this service and little detrimental effect on customers
or their business [41,42]. Pharmacists selling sterile inject-
ing equipment in Vietnam reported that they felt a
responsibility to prevent blood borne infection and were
willing to provide health education to customers that were
drug misusers [43]. More positive views were also reported
in a study in the USA with nearly all pharmacists (98%)
reporting that they felt they should play a part in helping
prevent the spread of blood borne infections such as HIV
and over two thirds supporting the availability of sterile
needles for purchase in community pharmacies [41].
Competence/Confidence
Findings regarding confidence and competence in pro-
viding health promotion services were mixed. A survey
of pharmacists in Scotland found that around one third
of participants did not feel that they were competent in
promoting and protecting the populations’ health or
encouraging behavioural change [21]. Around two thirds
felt they lacked the underpinning knowledge and one
third felt they could not apply their knowledge. Pharma-
cists taking part in a survey in Moldova rated their com-
petence in health promotion activities at between 2.9
and 3.6 (0 = low competence and 5 = high competence)
which was lower than competence scores for all other
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aspects of professional practice [65]. In contrast, the
majority of pharmacists (95%) in a survey in Nigeria felt
confident in advising patients on health promotion [71].
Pharmacists in Australia were reasonably confident in
providing a smoking cessation service, with a mean con-
fidence score of 3.7 (1 = not confident and 5 = extre-
mely confident), and did not report confidence as a
major barrier to smoking cessation activity [19]. Nearly
all participants (92%) in a study in Canada [33] agreed
that pharmacists can be effective in promoting smoking
cessation with most customers. In another study in the
USA around two thirds of pharmacists thought that the
effectiveness of pharmacist counselling was average or
good [55]. In two of these studies confidence was found
to be the greatest predictor of the amount of smoking
cessation activity reported and in one perceived effec-
tiveness was also a significant predictor [19,55].
Confidence in advising on the prevention HIV/hepatitis
was fairly low in pharmacists in a survey in Scotland [73].
Around half of pharmacists felt confident in advising cus-
tomers on prevention of HIV and around a third on
Hepatitis B/C. Confidence in advising on safer sex was
higher with the majority of pharmacists reporting that
they would be able to give advice on this to any customer
or a drug misuser (78% and 72% respectively). However,
only around one third were confident in advising a gay
man on safer sex (35%) [73]. Support staff in a similar
survey in Scotland reported lower confidence for advising
on safer sex than pharmacists [74]. Only half of support
staff felt able to give accurate advice to any customer
(51%) and one third a drug misuser (34%) or a gay man.
Pharmacists’ confidence in achieving positive outcomes
in weight management counselling was low in one study.
Pharmacists in a study in the USA reported mean confi-
dence (1 = not at all confident and 5 = extremely confi-
dent) scores of only 3.0 for achieving weight loss in
patients as a result of pharmacist counselling and 2.8 for
achieving consumption of a calorie controlled diet in
patients [18]. Mean confidence scores for medicine
related aspects of obesity counselling (e.g. minimisation
of adverse effects of anti-obesity medication) were higher
at between 3.3 and 3.4. Self reported frequency of obesity
counselling was found to be positively correlated with
confidence in achieving positive outcomes. Confidence in
providing brief alcohol screening and interventions was
also low with over half of pharmacists in a study in New
Zealand feeling neutral or disagreeing that they could
appropriately advise patients about drinking [61].
Barriers
A number of common barriers to public health practice
were highlighted across the different services. These
included availability of a private counselling area, time,
customer demand/reaction and reimbursement for pub-
lic health services.
The findings regarding a lack of private counselling
area were mixed. This was identified as a main barrier
to providing advice on health promotion in focus groups
in Sweden and advice on prevention of HIV/hepatitis in
pharmacists and support staff in Scotland [56,73,74].
Nearly two thirds of pharmacists in a survey in Canada
felt that having a designated space in pharmacy was
very or somewhat important in facilitating smoking ces-
sation practice and nearly half of participants in a study
in Thailand (43%) thought the pharmacy setting was
barrier to smoking cessation counselling [35,45]. Phar-
macists’ perception of having adequate facilities was
found to be a significant predictor of frequency of
smoking cessation counselling in one study [55].
Although a predictor of service provision, the majority
of pharmacists (71.7%) in this study did not view the
pharmacy setting was an important barrier to smoking
cessation counselling. Similarly, pharmacists in Nigeria
(93.1%) did not think facilities were a barrier to patient
interaction in relation to health promotion generally
[71]. Pharmacists interviewed in England also felt they
had adequate facilities to provide a Chlamydia testing
and treatment service [22].
Lack of time was identified as a main barrier to provid-
ing advice on prevention of HIV/hepatitis by pharmacists
and support staff in Scotland and for health promotion
activities by the majority (75%) of pharmacists in a study
in Malaysia [73-75]. Between 50 and 70% of participants
in two studies in the USA and one in Thailand agreed
that time was a barrier to providing smoking cessation
counselling and over half in one of the USA studies felt
that they were not adequately staffed for providing smok-
ing cessation services [15,55,45]. Similarly, around 70% of
participants in a study in New Zealand thought that
being too busy was a barrier to carrying out brief alcohol
screening [61]. Time was reported as a barrier to provid-
ing EHC by 67% of pharmacists surveyed in a study in
the USA [67]. However, a study on health promotion in
Nigeria and another on Chlamydia testing in England
reported that time was not an issue in providing these
services [71,22].
Views on patient demand for public health services in
community pharmacy and patient reactions to being
offered these services were mixed. Around 60% of phar-
macists in a survey in Thailand reported that lack of
patient demand was a barrier to providing smoking cessa-
tion services [45]. Focus group participants in Sweden also
perceived that patients had low expectations of receiving
health promotion advice from pharmacists [56]. Further-
more, over half of pharmacy assistants in a survey in Scot-
land felt that client embarrassment was a barrier to
offering advice on HIV/hepatitis prevention and a similar
proportion of pharmacists in a study in New Zealand felt
that patients would resent being asked about their alcohol
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consumption [74,61]. Pharmacists interviewed in the USA
reported that they viewed this as a sensitive topic and
were hesitant to initiate conversations about smoking as
they expected to receive a negative response from custo-
mers [62].
In contrast, the majority of participants in surveys on
health promotion and smoking cessation in Nigeria, the
USA and Finland did not think that lack of demand was
a barrier and thought that patients were motivated to
seek health advice from pharmacists, welcomed and
valued this advice and were not discouraged from
returning to the pharmacy as a result of being offered
advice [71,33,55,37]. Pharmacists in a survey carried out
in the USA agreed that customers are becoming more
willing to discuss health problems and more accepting
of counselling provided by pharmacists, but did not
agree as strongly that customers were more accepting of
pharmacists managing chronic disease [76]. Finally,
pharmacists involved in offering a Chlamydia testing
service reported that client reactions were to being
offered the service were mixed but that they were pre-
dominantly satisfied as long as discretion was used [22].
Reimbursement for providing public health services does
not seem to be a barrier for most pharmacists. The major-
ity of participants (63.7%) in a study in Malaysia felt neu-
tral or disagreed that a lack of reimbursement was a
barrier to their involvement in health promotion and most
pharmacists (87.6%) in a survey in Nigeria agreed that it is
alright to be involved in health promotion whether there
is reimbursement or not [75,71]. Studies in the USA, Thai-
land, and Canada also reported similar findings in relation
to smoking cessation [55,45,33,34].
Training
A need for training was identified in a number of surveys
on different public health services. Over half of pharmacists
in a study in Scotland reported that attaining additional
pharmaceutical public health knowledge was a priority for
their practice now and two thirds thought it would be a
priority in the future [21]. Between one third and one half
of pharmacists in three studies felt that lack of training or
lack of knowledge and skills was a barrier to their smoking
cessation practice [15,50,55]. Pharmacists and support staff
in Scotland also felt that lack of training was a main diffi-
culty in providing advice on prevention of HIV/hepatitis
and over 80% of pharmacists in a study in New Zealand
felt it was a barrier to providing alcohol screening and brief
interventions [73,74,61]. Over 70% of pharmacists in a sur-
vey in Scotland reported that they would like further train-
ing on drug misuse [59]. The majority of pharmacists in
Nigeria felt that they had good knowledge on health pro-
motion (86.9%) but also agreed that they would be willing
to retrain on health promotion (93.2%) [71].
Pharmacists taking part in a smoking cessation train-
ing needs assessment in Canada reported that training
would be helpful on all aspects of smoking cessation
practice but rated training on behavioural techniques for
quitting smoking and motivating patients as most help-
ful [34]. Pharmacists in Scotland taking part in a survey
on training needs for working with drug misusers most
often cited motivational and counselling skills as areas
they would like more training on [77]. No clear area for
future training was identified in a survey in Scotland
with the majority of pharmacists agreeing (79.3%) that
training should focus on generic knowledge and skills
but also with the statement that training should focus
on priority health issues such as chronic heart disease
(77.2%) [21]. Training for pharmacy technicians on
smoking cessation was found to significantly increase
knowledge, confidence and perceptions of the effective-
ness of smoking cessation counselling in a study in the
USA [24].
Consumers
The attitudes and beliefs of the general public and phar-
macy customers towards pharmaceutical public health
investigated in the papers in this review related to four
topics: use of community pharmacies, appropriateness of
pharmacists’ involvement in public health, satisfaction
with pharmaceutical public health and perceptions of
pharmacists’ ability.
Use of community pharmacies
A survey of pharmacy customers in Australia found that
the majority had never received advice on diet and exer-
cise (88.2%) or on preventing health problems (65.1%)
from a pharmacist [47]. The majority of smokers (57.8%)
in the sample also reported having never received advice
on smoking from a pharmacist.
Most pharmacy customers in a survey in Sweden
expected to receive information from pharmacists on
drugs (80.5%), while only around a third (36%) expected
information on general health issues and less than a quar-
ter expected advice on diet (24%), smoking cessation
(21%) or disease/illness (20.5%) [78]. Users of nicotine
replacement therapy in a survey in the USA found it most
useful and were most likely to discuss medicine related
smoking cessation topics (e.g. side effects of smoking ces-
sation medication) with a pharmacist and were least likely
and found it least useful to discuss behavioural topics (e.g.
how to cope with difficulties encountered) [52]. A survey
of pharmacy customers in Nigeria found that satisfaction
was lower for the availability of public health services than
other medicine related services [20].
Appropriateness of pharmacists’ involvement in public
health
The majority of participants in studies on smoking ces-
sation (83%), health screening and promotion (71% and
74% respectively), EHC (65%), services for drug misusers
and Chlamydia testing (75%) thought that pharmacists
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were appropriate providers of these services [17,56,
49,64,70]. Users of nicotine replacement therapy in a
study in the USA on average rated the appropriateness
of pharmacists taking an active role in smoking cessa-
tion as 6.9 out of 10 (1 = not at all appropriate and
10 = extremely appropriate) [52]. However, less than
one quarter (22%) of participants surveyed at a medical
centre thought that pharmacists should monitor long
term conditions such as asthma [59].
Satisfaction with pharmaceutical public health
Although it seems that customers often do not expect or
receive advice from pharmacists on public health topics,
satisfaction in those that have experienced pharmacy
public health services is high. A survey in Australia found
significantly more positive attitudes in those that had
experience of pharmacy health screening or promotion
than those that did not [57]. Attitudes in those with no
experience of public health services were also found to be
significantly more positive compared to a similar survey
carried out around seven years previously.
Nearly all individuals receiving community pharmacy
osteoporosis screening and education in two surveys in
the USA reported that the information provided increased
awareness (98%), that they were satisfied with the interac-
tion (92%) and found the advice valuable or highly valu-
able [79,53]. The majority of participants receiving self
management interventions from community pharmacists
for asthma (89%) and diabetes (97.5%) were also satisfied
with the care they received from the pharmacist [54,80].
Only 71% and 61% of those receiving the asthma self man-
agement interventions were satisfied by the education and
counselling provided by physicians and nurses respectively
[54].
Participants in a survey in the USA reported very posi-
tive experiences of community pharmacy based smoking
cessation services [40]. Patients’ agreement with ten state-
ments about their satisfaction with the service (1 = lowest
satisfaction and 10 = highest satisfaction) was high with
mean scores between 8.5 and 9.9 for all of the statements.
Intravenous drug users taking part in focus groups in
Estonia reported that pharmacies were more convenient
and easier to access than other needle exchange services,
but that they experienced discomfort and embarrassment
as a result of perceived negative attitude of the pharmacist
and other customers towards them [58].
Women who received EHC from community pharmacy
reported largely positive experiences of this service. The
majority of women participating in surveys, interviews
and focus groups in the USA, Canada and England
reported that they were satisfied with their consultation
with the pharmacist [81,82,27,48,69]. Over 80% of
women in the survey conducted in the USA and another
in Canada were satisfied with the amount of privacy in
the pharmacy [81,27]. The flexibility and convenience of
the pharmacy setting were viewed as benefits to this set-
ting and were the primary reason for attending pharmacy
over than other settings such as family planning clinics
[63,82,69]. Indeed the majority of women (65%) sampled
for a study in Sweden reported that they would prefer to
purchase EHC from a pharmacy over visiting a clinic
with availability selected as the motive for this choice by
most women (64%) [66].
Despite largely positive views towards the service, con-
cerns were reported by women in some studies. Some
participants in focus groups in Europe, interviews in Eng-
land and interviews in the UK felt that there were issues
with privacy in the community pharmacy setting
[51,48,63]. Significantly more women who obtained EHC
from other services (e.g. family planning clinics) in the
survey in England reported that they felt comfortable,
had adequate privacy, adequate advice, and had discussed
future contraception than those attending pharmacy [48].
Participants in the focus groups in Europe and Sweden
also expressed mixed views on their interaction with the
pharmacists [51,25]. Some participants perceived that the
pharmacist was judgemental towards them in the consul-
tation [51,25].
The majority of women surveyed after taking a postal
Chlamydia testing kit from a pharmacy in Amsterdam
reported that it was a good method of screening (68%)
[23]. In a similar study in England, the majority of cus-
tomers taking a Chlamydia testing kit were very satisfied
with the service (80%), found the consultation suffi-
ciently private (95%) and were comfortable discussing
sexual health with the pharmacist (100%) [70]. In tele-
phone interviews participants commented on the excel-
lent communication skills of the pharmacist and the
short waiting times and anonymity at the pharmacy.
However, the interviews also revealed that while custo-
mers were satisfied with the confidentiality of the con-
sultation, there were concerns regarding confidentiality
at the counter [70].
Perceptions of pharmacists’ ability
Around one third of pharmacy customers in a survey in
the UK were unsure if the pharmacist was qualified to
issue advice on sexual health issues or had enough
experience or knowledge to deal with sexual health
related issues [44]. Approximately three quarters of
patients surveyed at a medical centre in the USA were
undecided, disagreed or strongly disagreed with the state-
ment that pharmacists are trained to provide smoking
cessation services [17]. Those that reported a greater fre-
quency of discussing medications with their pharmacists
were more likely to agree or strongly agree with the state-
ment. In a sample of the general public in the USA, 82%
and 94.2% of participants respectively thought that phar-
macists and physicians would be a very good or some-
what good source of advice on quitting smoking [36].
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Nicotine replacement therapy users in a survey in the
USA rated pharmacists’ smoking cessation knowledge as
highest in relation to prescription medicines at an aver-
age of 8.1 out of a maximum score of 10 and lowest in
relation to knowledge of non-drug strategies to help
tobacco users to quit at an average of 4.0 [52].
Patients with type 2 diabetes in a study in the United
Arab Emirates showed a significant increase in their per-
ceptions of pharmacists’ ability to help them to reduce
their blood sugar after receiving a pharmacist led self man-
agement intervention [46]. At baseline 32% of participants
agreed or strongly agreed that their pharmacist can help
decrease their blood sugar and 92% agreed or strongly
agreed with the same statement for their doctor. Over half
of participants (56%) agreed or strongly agreed that the
pharmacist could help after receiving the intervention. A
survey in Sweden found that around three quarters of
pharmacy customers thought that pharmacy could influ-
ence people’s willingness to improve their health [78].
Discussion
Pharmacy staff
The majority of pharmacists in the review were positive
about providing public health services and felt that this
was an important role. This suggests that the changing
role of community pharmacy from traditional dispensing
activities to greater involvement in health improvement is
largely accepted, and the importance of providing these
services is understood. However, the review indicates that
the public health role is still considered secondary to med-
icine related roles. Pharmacists viewed public health activ-
ities as less important than traditional roles and were less
confident in providing these. Less positive views were also
held by some pharmacists in relation to certain public
health services, particularly services for drug misusers.
These findings are consistent with those of the previous
systematic reviews on this topic [6,7,12].
Reported levels of confidence in providing public health
services varied from service to service in the current
review, but on the whole were average to low. Confidence
in our ability to perform a behaviour (known as self effi-
cacy) has been found to be crucial in predicting whether
we engage in the behaviour [83]. A review found that self
efficacy can predict as much as 35% of the variance in
behaviour [84]. This link between confidence and beha-
viour was supported in the current review with two studies
reporting that confidence was the greatest predictor of self
reported smoking cessation activity in pharmacists [19,55].
This review and the previous review identified a need
for further training for a number of different public
health services. Encouragingly, training was found to
have a positive effect on pharmacists’ attitudes in the
previous reviews [6,7,10]. Although very few studies in
the current review assessed specific areas for future
training, the findings of the review do suggest how
training may be best targeted. A study on drug misuse
and another on smoking cessation indicated that train-
ing on motivating patients and behavioural techniques
would be most useful [77,34]. Training for health pro-
fessionals often devotes time to explaining the impor-
tance of the health issue in question and what part the
professional can play in tackling this. However, the find-
ings of this review suggest that pharmacists understand
this and that tackling pharmacists’ self efficacy may have
a much greater impact on practice. Although self effi-
cacy is an important determinant of behaviour, there is
limited evidence on interventions to increase self effi-
cacy [85]. Therefore, further research is needed to inves-
tigate interventions to increase pharmacists’ self efficacy
for providing public health services.
Although most studies found that a lack of patient
demand and negative customer reactions were not a
barrier to public health practice, some pharmacists did
perceive these to be a problem. Similarly, the previous
review found that pharmacists were concerned about
being intrusive when offering public health services.
These beliefs could be addressed during training by out-
lining the results of research on customer experiences of
pharmaceutical public health.
Time was fairly consistently identified in the current
review as a barrier to a number of public health services.
Similarly, the previous review reported that dispensing
duties were a barrier to public health activities. Findings
in the current review were more mixed regarding avail-
ability of an adequate counselling space as a barrier to
public health practice, which may reflect differences in
availability of counselling areas rather than differences in
perceptions of their importance. Remuneration for pro-
viding public health services was not reported to be a
barrier in the current review suggesting that current
levels of remuneration are perceived to be adequate.
Only three studies in the current review reported the
attitudes of support staff separately from those of pharma-
cists [22,56,30]. Fewer support staff reported that they
were confident in providing accurate advice on prevention
of HIV and hepatitis [22] than pharmacists in another
similar survey [18]. Support staff are often the first point
of contact for pharmacy customers and can play a vital
role in alleviating the time pressures on pharmacists by
offering public health services and carrying out initial
screening. Research is needed to establish the attitudes of
support staff to allow support and training to be appropri-
ately targeted for this group.
Consumers
Customer attitudes towards pharmaceutical public
health were on the whole quite positive. Customers
found the pharmacy a convenient setting and felt that
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pharmacists should provide public health services. Those
that had experienced public health services in commu-
nity pharmacy, such as self management interventions,
emergency hormonal contraception and Chlamydia
screening, were largely satisfied with their experience of
these. However, two studies revealed that most custo-
mers did not expect, and had never been offered, public
health advice from a pharmacist [47,78]. This suggests
that pharmacists’ perceptions of low demand for public
health services are accurate. However, the expectation of
a negative customer reaction to pharmaceutical public
health services held by some pharmacists seems to be
unfounded. These findings are also consistent with
those of the previous systematic reviews in the area
[6,7,12]. Customers in the previous review valued the
pharmacists input in public health services, but per-
ceived pharmacists as drug experts and did not often
use pharmacies for general health advice.
Customers’ perceptions of pharmacists’ ability to pro-
vide public health services were mixed in the current
review, with some perceiving pharmacists as good
sources of advice on health and other not. One study
found a significant increase in customers’ perceptions of
pharmacists’ ability after receiving a diabetes self man-
agement intervention from pharmacist. Similarly another
study reported significantly more positive attitudes in
members of the public who had experienced pharmacy
health screening or promotion than those that had not.
Issues with privacy were raised in four studies investi-
gating sexual health services in community pharmacy
and were also highlighted in the previous review on cus-
tomer attitudes [48,51,63,70,11]. Although private coun-
selling areas are becoming more common in pharmacy,
these studies highlight that there are still issues with
privacy, particularly at the pharmacy counter. The nat-
ure of the pharmacy setting can make complete privacy
difficult to achieve, but future projects involving sensi-
tive topics such as sexual health must make attempts to
remedy this issue.
Pharmaceutical public health services are clearly well
received by those that experience them and result in high
levels of satisfaction. Considering the findings of this
review, it seems likely that the more these services are
offered and experienced by the general public, the more
positive attitudes will become. Successfully changing the
public’s perception of pharmacist in this way will require
pharmacists to be proactive in offering public health ser-
vices. As discussed, pharmacists may need additional sup-
port and training in order to feel confident about doing
this.
Limitations of the review
Heterogeneity in the included studies reduced the ability
of the review to summarise trends and may have
accounted for some of the inconsistencies in findings.
Studies were conducted in a variety of countries across
the world with differing health care systems and it is
not known how these different cultures and systems
may affect customer and pharmacy staff attitudes. A
number of factors increased the risk of bias within the
included studies. Response rates were generally average,
with the majority of studies achieving rates of 50% and
over. One quarter of studies did not report response
rates and only three studies followed up and assessed
non-respondents. Convenience sampling was used in the
majority of studies included in the review. These factors
may mean that the views of those sampled were not
representative of the population as a whole and there-
fore limit the generalisability of the findings.
Conclusions
The consistency of the findings of the current review
with the previous reviews is striking. Despite the intro-
duction of public health services to the pharmacy con-
tract in the UK, current attitudes of pharmacists and the
public appear to be largely similar to before these
changes. Although this is discouraging it is perhaps not
surprising considering the magnitude of the changes
pharmacists have experienced in their role. Around half
of non-UK papers and one third of UK papers in the
present review were published prior to the introduction
of the new pharmacy contract in the UK (See table 2).
This fact considered with the possible lag between
research being conducted and published may also partly
explain why there was little difference found in attitudes
between the current and previous systematic reviews.
It is important that the positive attitudes of pharma-
ceutical public health users and pharmacists found in
both reviews are extended and built upon. Appropriate
training and support is needed in order increasing phar-
macists’ confidence in providing public health services.
Future research needs to investigate the effectiveness of
strategies for increasing pharmacists’ confidence and
changing their public health practice. If pharmacists can
be supported to offer public health services more proac-
tively, it is likely that increased exposure to public
health services will have a positive effect of the attitudes
and health of the general public.
Additional material
Additional file 1: Characteristics of included studies. Excel table
showing characteristics of studies included in the review.
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